Results 181 to 190 of about 4,427,331 (285)

Recurrent bladder cancer associated with vulvar pagetoid lesion.

, 2000
Toshiyuki Ishizawa, Yuhko ABE, Masatoshi Oyama, Shin Koseki, Yohtaro Katagata, Yoshihiko Mitsuhashi, Shigeo Kondô, Toshiaki Suzuki, Shigeru Kuroki, Kiyoo Koseki   +9 more
openalex   +2 more sources

Nucleotide variation in IL‐10 and IL‐12 and their receptors and cervical and vulvar cancer risk: A hybrid case–parent triad and case–control study [PDF]

, 2012
Shehnaz K. Hussain, Margaret M. Madeleine, Lisa Johnson, Qin Du, Denise A. Galloway, Janet R. Daling, Mari Malkki, Effie W. Petersdorf, Stephen M. Schwartz   +8 more
openalex   +1 more source

Malignant Melanoma of the Urethra: A Rare Histologic Subdivision of Vulvar Cancer with a Poor Prognosis [PDF]

, 2012
Veronika Günther, İbrahim Alkatout, Cvjetko Lež, Silvio Altarac, Rajko Fureš, Hrvoje Čupić, Zoran Peršec, Zlatko Hrgović, Christoph Mundhenke   +8 more
openalex   +1 more source

Requiring Human Papilloma Virus Vaccination for School Entry [PDF]

, 2018
Over 40,000 Americans are diagnosed as having HPV-associated cancer each year, including oropharyngeal cancer for men and cervical cancer for women.
Bayefsky, Michelle J., Gostin, Lawrence O.   +1 more
core   +1 more source

Listening to Women's Voices: A Patient and Public Involvement Exercise Exploring Vulval Reconstructive Surgery for UK Women With Female Genital Mutilation (FGM)

Health Expectations, Volume 28, Issue 3, June 2025.
ABSTRACT Introduction This article presents patient and public involvement and engagement (PPIE) work undertaken to explore FGM survivors' and stakeholders' views on reconstructive surgery, potential service models, care pathways, barriers to access and other support needs.
Juliet Albert, Janet Fyle, Njomeza Kartallozi, Christie Coho, Naana Otoo‐Oyortey, Hekate Papadaki, Catrin Evans, Dalia Saidan, Sohier Elneil, Natasha Anderson‐Foster, Jasmine Abdulcadir, Huda Mohamed, Aurora Almadori   +12 more
wiley   +1 more source

Expression and prognostic relevance of endothelin-B receptor in vulvar cancer

, 2007
Elke Eltze, Matteo Bertolin, Eberhard Korsching, P Wülfing, T Maggino, Ralph J. Lellé   +5 more
openalex   +2 more sources

Mohs Micrographic Surgery Versus Wide Local Excision in the Treatment of Anogenital Squamous Cell Carcinoma: A Systematic Review

International Journal of Dermatology, Volume 64, Issue 6, Page 1042-1048, June 2025.
ABSTRACT Primary anogenital squamous cell carcinoma (SCC) is a locally aggressive malignancy that requires careful consideration of surgical margins. Anogenital SCC impacts the quality of life due to tissue removal, scarring, and sexual dysfunction. Mohs micrographic surgery (MMS) offers a compelling alternative to wide local excision (WLE) due to its ...
Sujitha Yadlapati, Priscilla M. Rosa‐Nieves, Kyle C. Lauck, Stanislav N. Tolkachjov   +3 more
wiley   +1 more source

Vulvar Cancer-Related Hospitalizations In The United States: A Retrospective Population-Based Case-Control Study [PDF]

, 2013
Z. Shahpurwala, Rahul Khanna
openalex   +1 more source

Women's Experience and Management of Cancer‐Related Fatigue and Psychological Distress During Treatment for Gynaecological Cancer: A Qualitative Study

Journal of Advanced Nursing, Volume 81, Issue 6, Page 3213-3225, June 2025.
ABSTRACT Aim To explore women's experience and management of cancer‐related fatigue and psychological distress during treatment for gynaecological cancer. Design Qualitative descriptive study. Methods Face‐to‐face semistructured individual interviews were conducted with 23 women in mainland China undergoing treatment for gynaecological cancer between ...
Xing Ma, Qian Wang, Dorothy Ngo Sheung Chan   +2 more
wiley   +1 more source

Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 6, Page 1152-1162, June 2025.
ALLEGRO‐LT (NCT04006457) is an open‐label, phase 3 study investigating the long‐term safety and efficacy of ritlecitinib in patients with alopecia areata (AA). In this analysis in 449 de novo patients with AA and ≥25% scalp hair loss, ritlecitinib demonstrated clinical efficacy and had an acceptable safety profile through Month 24.
C. Tziotzios, R. Sinclair, A. Lesiak, S. Mehlis, M. Kinoshita‐Ise, A. Tsianakas, X. Luo, E. H. Law, R. Ishowo‐Adejumo, R. Wolk, M. Sadrarhami, A. Lejeune   +11 more
wiley   +1 more source